Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Genomics Market: By Product: Consumables, Systems and Software, Services; By Technology: PCR, Sequencing, Microarray, Others; By Application; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Value Chain Analysis; Competitive Landscape; Industry Events and Developments
Global Genomics Market Outlook
The global genomics market was estimated at USD 16.21 billion in 2020 and is expected to grow at a CAGR of 9.3% over the forecast period of 2022-2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for genomics is driven by the genomic data pool, which has resulted in the development of the study operations, allowing physicians, biologists, and patients to further explore the genetic predisposition to certain illnesses. It is anticipated that the clinical implementation of this data pool will play a significant part in transforming the healthcare system with regard to providing more precise, efficient, and reliable alternatives for disease management.
Global Genomics Market: Properties and Applications
Genomics is referred to as the branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The genomics market can be divided based on segments like product, technology, application, and end-use.
The genomics industry is broadly divided on the basis of product into:
- Consumables
- Systems and Software
- Services
Based on technology, the genomics market is divided into:
- PCR
- Sequencing
- Microarray
- Nucleic Acid Extraction and Purification
- Others
The genomics market is segmented on the basis of application into:
- Diagnostics
- Drug Discovery and Development
- Precision Medicine
- Agriculture and Animal Research
- Others
Based on end-uses, the genomics market is divided into:
- Research Centres and Academic and Government Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
The EMR report looks into the regional genomics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Genomics Market Analysis
The global genomics market is driven by the application of human genetic research in multiple government health programs such as consumer wellness programs, demographic screening, and others. The key objectives of the programs are to optimize preventive care for prevalent chronic diseases such as cancer and heart disease. The growing investment by government agencies, financing departments, and biotechnology firms to accelerate genomic research is expected to have significant implications for the genomics market reshaping. International financing agencies such as NIH and Welcome Trust are committed to offering to finance genetic research, which is supposed to boost genomic research in both advanced and emerging countries, further aiding the global genomics market.
Global Genomics Market: Competitive Landscape
The report presents a detailed analysis of the following key players in the global genomics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Illumina, Inc. (NASDAQ: ILMN)
- Qiagen
- Eurofins Scientific
- Agilent Technologies, Inc.
- Oxford Nanopore Technologies
- F. Hoffmann-La Roche
- Bio-Rad Laboratories, Inc.
- BGI Group
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Technology, Application, End Use, Region |
| Breakup by Product | Consumables, Systems and Software, Services |
| Breakup by Technology | PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, Others |
| Breakup by Application | Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture and Animal Research, Others |
| Breakup by End Use | Research Centres and Academic & Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Illumina, Inc. (NASDAQ: ILMN), Qiagen (NYSE: QGEN), Eurofins Scientific (EPA: ERF), Agilent Technologies, Inc. (NYSE: A), Oxford Nanopore Technologies, F. Hoffmann-La Roche (SWX: ROG), Bio-Rad Laboratories, Inc. (NYSE: BIO), BGI Group, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Genomics Market Analysis
8.1 Key Industry Highlights
8.2 Global Genomics Historical Market (2017-2021)
8.3 Global Genomics Market Forecast (2022-2027)
8.4 Global Genomics Market by Product
8.4.1 Consumables
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Systems and Software
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Services
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.5 Global Genomics Market by Technology
8.5.1 PCR
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Sequencing
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Microarray
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Nucleic Acid Extraction and Purification
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Others
8.6 Global Genomics Market by Application
8.6.1 Diagnostics
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Drug Discovery and Development
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Precision Medicine
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.6.4 Agriculture and Animal Research
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2017-2021)
8.6.4.3 Forecast Trend (2022-2027)
8.6.5 Others
8.7 Global Genomics Market by End Use
8.7.1 Research Centres and Academic and Government Institutes
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 Hospitals and Clinics
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.7.3 Pharmaceutical and Biotechnology Companies
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2017-2021)
8.7.3.3 Forecast Trend (2022-2027)
8.7.4 Others
8.8 Global Genomics Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Illumina, Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 QIAGEN GmbH
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Eurofins GSC Lux SARL
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Agilent Technologies, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Oxford Nanopore Technologies Limited
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 F. Hoffmann-La Roche
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Bio-Rad Laboratories, Inc.
12.2.7.1 Company Overview
12.2.7.2 Product Portfolio
12.2.7.3 Demographic Reach and Achievements
12.2.7.4 Certifications
12.2.8 BGI Group
12.2.8.1 Company Overview
12.2.8.2 Product Portfolio
12.2.8.3 Demographic Reach and Achievements
12.2.8.4 Certifications
12.2.9 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Genomics Market: Key Industry Highlights, 2017 and 2027
2. Global Genomics Historical Market: Breakup by Product (USD Billion), 2017-2021
3. Global Genomics Market Forecast: Breakup by Product (USD Billion), 2022-2027
4. Global Genomics Historical Market: Breakup by Technology (USD Billion), 2017-2021
5. Global Genomics Market Forecast: Breakup by Technology (USD Billion), 2022-2027
6. Global Genomics Historical Market: Breakup by Application (USD Billion), 2017-2021
7. Global Genomics Market Forecast: Breakup by Application (USD Billion), 2022-2027
8. Global Genomics Historical Market: Breakup by End Use (USD Billion), 2017-2021
9. Global Genomics Market Forecast: Breakup by End Use (USD Billion), 2022-2027
10. Global Genomics Historical Market: Breakup by Region (USD Billion), 2017-2021
11. Global Genomics Market Forecast: Breakup by Region (USD Billion), 2022-2027
12. North America Genomics Historical Market: Breakup by Country (USD Billion), 2017-2021
13. North America Genomics Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Europe Genomics Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Europe Genomics Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Asia Pacific Genomics Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Asia Pacific Genomics Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Latin America Genomics Historical Market: Breakup by Country (USD Billion), 2017-2021
19. Latin America Genomics Market Forecast: Breakup by Country (USD Billion), 2022-2027
20. Middle East and Africa Genomics Historical Market: Breakup by Country (USD Billion), 2017-2021
21. Middle East and Africa Genomics Market Forecast: Breakup by Country (USD Billion), 2022-2027
22. Global Genomics Market Structure
Key Questions Answered in the Report
In 2020, the global genomics market attained a value of nearly USD 16.21 billion.
The market is projected to grow at a CAGR of 9.3% between 2021 and 2026.
The major drivers of the industry, such as the growing scientific research and innovation focused on genomics, growing prevalence of cancer, government organised consumer wellness programmes, and growing technological advancements, are expected to aid the market growth.
The key market trends guiding the growth of the market include the development in the field of non-invasive cancer screening-based research, growing clinical trials and increased funding for research, and government genomics initiatives.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major genomics products in the industry include consumables, systems and software, and services.
The significant technologies in the industry include PCR, sequencing, microarray, and nucleic acid extraction and purification, among others.
Diagnostics, drug discovery and development, precision medicine, and agriculture and animal research, among others, are the leading applications of genomics.
The major end use sectors of the product include research centres and academic and government institutes, hospitals and clinics, and pharmaceutical and biotechnology companies, among others.
The major players in the industry are Illumina, Inc., Qiagen, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies, F. Hoffmann-La Roche, Bio-Rad Laboratories, Inc., and BGI Group, among others.
Analyst Review
The global genomics market attained a value of USD 16.21 billion in 2020, driven by the growing research and clinical trials in the field of genomes. Aided by the technological advancements and increased funding to accelerate genomic research, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 9.3%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on products, the genomics industry can be segmented into consumables, systems and software, and services. On the basis of technology, the genomics market is divided into PCR, sequencing, microarray, nucleic acid extraction and purification, and others. On the basis of applications, the industry is divided into diagnostics, drug discovery and development, precision medicine, and agriculture and animal research, among others. Based on end use, the industry is categorised into research centres and academic and government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others. The major regional markets for genomics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Illumina, Inc., Qiagen, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies, F. Hoffmann-La Roche, Bio-Rad Laboratories, Inc., and BGI Group, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global cardiac troponin market has been driven by the increasing prevalence of acute coronary syndrome in the historical period. Aided by the increasing investments and rising demand for cardiac b...
The global gas chromatography market attained a value of nearly USD 2.92 billion in 2021, driven by the growing product demand in major end use industries, and rapid urbanisation. Aided by the growing...
The global B-hydroxybutyrate (ketone body) assay kits market is driven by the rising end uses of the product in hospitals and clinics. Aided by the growing R&D activities, the market is expected to wi...
The global clinical diagnostics market attained a value of more than USD 63.41 billion in 2021, driven by the rising prevalence of chronic diseases, increasing geriatric population, and rising healthc...
The global non-invasive prenatal testing (NIPT) market attained a value of about USD 1.74 billion in 2021, driven by the rising incidence of chromosomal abnormalities. Aided by the growing technologic...
NEWSLETTER